Manidipine Biogaran (Manidipine Dihydrochloride)

Manidipine blocks L‑type calcium channels in the smooth muscle of blood vessels. By preventing calcium entry, it causes the vessels to relax and widen (vasodilation), which lowers peripheral resistance and consequently reduces systemic blood pressure.

The appropriate dose of manidipine is determined by the prescribing healthcare professional based on the individual’s clinical condition, response to therapy, and any concomitant medications. Patients should follow the specific dosing instructions provided by their prescriber.

Safety data for manidipine in pregnancy and lactation are limited, and the drug is generally not recommended unless the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should evaluate each case individually.

To request Manidipine Biogaran, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Manidipine belongs to the calcium channel blocker class, which primarily reduces blood pressure by vasodilation. Compared with ACE inhibitors or ARBs, which act on the renin‑angiotensin system, manidipine may be preferred when patients experience cough or angioedema with those agents, but individual response varies.

Manidipine tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect them from moisture, excessive heat, and direct sunlight to maintain product stability throughout its shelf life.

Manidipine Biogaran is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious adverse events, although rare, include severe hypotension, myocardial infarction, hepatic dysfunction, allergic reactions such as angioedema, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like fainting, chest pain, severe dizziness, or swelling of the face or throat.

Manidipine is contraindicated in patients with known hypersensitivity to the drug or any component of the formulation. It should also be avoided in individuals with severe aortic stenosis, uncontrolled heart failure, or those taking contraindicated medications that could cause dangerous drops in blood pressure.